CAS: 1371569-69-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoroMethyl)pyriMidine REF: IN-DA009ENLCAS: 1371569-69-5 | 97% | To inquire | Wed 12 Feb 25 |
 | BETP REF: TM-TQ0124CAS: 1371569-69-5 | 97.92% | 47.00 €~661.00 € | Wed 19 Feb 25 |
 | (4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine REF: 3D-FB98669CAS: 1371569-69-5 | Min. 95% | - - - | Discontinued product |
(4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoroMethyl)pyriMidine
CAS:1371569-69-5
Formula:
C20H17F3N2O2S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
406.4214
Ref: IN-DA009ENL
| 1g | To inquire | ||
| 5mg | 81.00 € | ||
| 50mg | 155.00 € | ||
| 100mg | 190.00 € | ||
| 250mg | 554.00 € |
Estimated delivery in United States, on Wednesday 12 Feb 2025
BETP
CAS:1371569-69-5
BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and …
Formula:
C20H17F3N2O2S
Purity:
97.92%
Color and Shape:
Solid
Molecular weight:
406.42
Ref: TM-TQ0124
| 1mg | 47.00 € | ||
| 5mg | 91.00 € | ||
| 10mg | 137.00 € | ||
| 25mg | 258.00 € | ||
| 50mg | 414.00 € | ||
| 100mg | 661.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Wednesday 19 Feb 2025
(4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine
CAS:1371569-69-5
4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine is a drug that is used as an insulinotropic agent. It was first synthesized …
Formula:
C20H17F3N2O2S
Purity:
Min. 95%
Molecular weight:
406.42 g/mol
Ref: 3D-FB98669
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information |
